CovidFranceV1, Main, Exploration, bibRecord, 000883

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.

Identifieur interne : 000883 ( Main/Exploration ); précédent : 000882; suivant : 000884

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.

Auteurs : Zhenguo Zhai [République populaire de Chine] ; Chenghong Li [République populaire de Chine] ; Yaolong Chen [République populaire de Chine] ; Grigorios Gerotziafas [France] ; Zhenlu Zhang [République populaire de Chine] ; Jun Wan [République populaire de Chine] ; Peng Liu [République populaire de Chine] ; Ismaïl Elalamy [France, Russie] ; Chen Wang [République populaire de Chine]

Source :

Thrombosis and haemostasis [ 2567-689X ] ; 2020.

RBID : pubmed:32316065

Descripteurs français

KwdFr :
- Anticoagulants (usage thérapeutique), Appréciation des risques (MeSH), Betacoronavirus (MeSH), Chine (épidémiologie), Consensus (MeSH), Embolie pulmonaire (complications), Embolie pulmonaire (prévention et contrôle), Enregistrements (MeSH), Europe (épidémiologie), Facteurs de risque (MeSH), Humains (MeSH), Hémorragie (prévention et contrôle), Infections à coronavirus (complications), Infections à coronavirus (sang), Infections à coronavirus (thérapie), Maladie grave (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (sang), Pneumopathie virale (thérapie), Produits de dégradation de la fibrine et du fibrinogène (analyse), Résultat thérapeutique (MeSH), Thromboembolisme veineux (complications), Thromboembolisme veineux (prévention et contrôle), Thromboembolisme veineux (thérapie), Thrombose veineuse (complications), Thrombose veineuse (prévention et contrôle), Troubles de l'hémostase et de la coagulation (traitement médicamenteux).
MESH :
- analyse : Produits de dégradation de la fibrine et du fibrinogène.
- prévention et contrôle : Embolie pulmonaire, Hémorragie, Thromboembolisme veineux, Thrombose veineuse.
- sang : Embolie pulmonaire, Infections à coronavirus, Pneumopathie virale, Thromboembolisme veineux, Thrombose veineuse.
- thérapie : Infections à coronavirus, Pneumopathie virale, Thromboembolisme veineux.
- traitement médicamenteux : Troubles de l'hémostase et de la coagulation.
- usage thérapeutique : Anticoagulants.
- épidémiologie : Chine, Europe.
- Appréciation des risques, Betacoronavirus, Consensus, Enregistrements, Facteurs de risque, Humains, Maladie grave, Pandémies, Résultat thérapeutique.
Wicri :
- geographic : République populaire de Chine.

English descriptors

KwdEn :
- Anticoagulants (therapeutic use), Betacoronavirus (MeSH), Blood Coagulation Disorders (drug therapy), China (epidemiology), Consensus (MeSH), Coronavirus Infections (blood), Coronavirus Infections (complications), Coronavirus Infections (therapy), Critical Illness (MeSH), Europe (epidemiology), Fibrin Fibrinogen Degradation Products (analysis), Hemorrhage (prevention & control), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (blood), Pneumonia, Viral (complications), Pneumonia, Viral (therapy), Pulmonary Embolism (complications), Pulmonary Embolism (prevention & control), Registries (MeSH), Risk Assessment (MeSH), Risk Factors (MeSH), Treatment Outcome (MeSH), Venous Thromboembolism (complications), Venous Thromboembolism (prevention & control), Venous Thromboembolism (therapy), Venous Thrombosis (complications), Venous Thrombosis (prevention & control).
MESH :
- chemical , analysis : Fibrin Fibrinogen Degradation Products.
- chemical , therapeutic use : Anticoagulants.
- geographic , epidemiology : China, Europe.
- blood : Coronavirus Infections, Pneumonia, Viral.
- complications : Coronavirus Infections, Pneumonia, Viral, Pulmonary Embolism, Venous Thromboembolism, Venous Thrombosis.
- drug therapy : Blood Coagulation Disorders.
- prevention & control : Hemorrhage, Pulmonary Embolism, Venous Thromboembolism, Venous Thrombosis.
- therapy : Coronavirus Infections, Pneumonia, Viral, Venous Thromboembolism.
- Betacoronavirus, Consensus, Critical Illness, Humans, Pandemics, Registries, Risk Assessment, Risk Factors, Treatment Outcome.

Abstract

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.

DOI: 10.1055/s-0040-1710019
PubMed: 32316065
PubMed Central: PMC7295267

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001645
to stream Main, to step Curation: 001645

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.</title>
<author><name sortKey="Zhai, Zhenguo" sort="Zhai, Zhenguo" uniqKey="Zhai Z" first="Zhenguo" last="Zhai">Zhenguo Zhai</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Li, Chenghong" sort="Li, Chenghong" uniqKey="Li C" first="Chenghong" last="Li">Chenghong Li</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Yaolong" sort="Chen, Yaolong" uniqKey="Chen Y" first="Yaolong" last="Chen">Yaolong Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou</wicri:regionArea>
<wicri:noRegion>Lanzhou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gerotziafas, Grigorios" sort="Gerotziafas, Grigorios" uniqKey="Gerotziafas G" first="Grigorios" last="Gerotziafas">Grigorios Gerotziafas</name>
<affiliation wicri:level="3"><nlm:affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, Zhenlu" sort="Zhang, Zhenlu" uniqKey="Zhang Z" first="Zhenlu" last="Zhang">Zhenlu Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wan, Jun" sort="Wan, Jun" uniqKey="Wan J" first="Jun" last="Wan">Jun Wan</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Peng" sort="Liu, Peng" uniqKey="Liu P" first="Peng" last="Liu">Peng Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elalamy, Ismail" sort="Elalamy, Ismail" uniqKey="Elalamy I" first="Ismaïl" last="Elalamy">Ismaïl Elalamy</name>
<affiliation wicri:level="3"><nlm:affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow</wicri:regionArea>
<placeName><settlement type="city">Moscou</settlement>
<region>District fédéral central</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32316065</idno>
<idno type="pmid">32316065</idno>
<idno type="doi">10.1055/s-0040-1710019</idno>
<idno type="pmc">PMC7295267</idno>
<idno type="wicri:Area/Main/Corpus">001645</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001645</idno>
<idno type="wicri:Area/Main/Curation">001645</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001645</idno>
<idno type="wicri:Area/Main/Exploration">001645</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.</title>
<author><name sortKey="Zhai, Zhenguo" sort="Zhai, Zhenguo" uniqKey="Zhai Z" first="Zhenguo" last="Zhai">Zhenguo Zhai</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Li, Chenghong" sort="Li, Chenghong" uniqKey="Li C" first="Chenghong" last="Li">Chenghong Li</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chen, Yaolong" sort="Chen, Yaolong" uniqKey="Chen Y" first="Yaolong" last="Chen">Yaolong Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou</wicri:regionArea>
<wicri:noRegion>Lanzhou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gerotziafas, Grigorios" sort="Gerotziafas, Grigorios" uniqKey="Gerotziafas G" first="Grigorios" last="Gerotziafas">Grigorios Gerotziafas</name>
<affiliation wicri:level="3"><nlm:affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, Zhenlu" sort="Zhang, Zhenlu" uniqKey="Zhang Z" first="Zhenlu" last="Zhang">Zhenlu Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wan, Jun" sort="Wan, Jun" uniqKey="Wan J" first="Jun" last="Wan">Jun Wan</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Peng" sort="Liu, Peng" uniqKey="Liu P" first="Peng" last="Liu">Peng Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elalamy, Ismail" sort="Elalamy, Ismail" uniqKey="Elalamy I" first="Ismaïl" last="Elalamy">Ismaïl Elalamy</name>
<affiliation wicri:level="3"><nlm:affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow</wicri:regionArea>
<placeName><settlement type="city">Moscou</settlement>
<region>District fédéral central</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>National Clinical Research Center for Respiratory Diseases, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Thrombosis and haemostasis</title>
<idno type="eISSN">2567-689X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticoagulants (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Blood Coagulation Disorders (drug therapy)</term>
<term>China (epidemiology)</term>
<term>Consensus (MeSH)</term>
<term>Coronavirus Infections (blood)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Critical Illness (MeSH)</term>
<term>Europe (epidemiology)</term>
<term>Fibrin Fibrinogen Degradation Products (analysis)</term>
<term>Hemorrhage (prevention & control)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (blood)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pulmonary Embolism (complications)</term>
<term>Pulmonary Embolism (prevention & control)</term>
<term>Registries (MeSH)</term>
<term>Risk Assessment (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Venous Thromboembolism (complications)</term>
<term>Venous Thromboembolism (prevention & control)</term>
<term>Venous Thromboembolism (therapy)</term>
<term>Venous Thrombosis (complications)</term>
<term>Venous Thrombosis (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticoagulants (usage thérapeutique)</term>
<term>Appréciation des risques (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Chine (épidémiologie)</term>
<term>Consensus (MeSH)</term>
<term>Embolie pulmonaire (complications)</term>
<term>Embolie pulmonaire (prévention et contrôle)</term>
<term>Enregistrements (MeSH)</term>
<term>Europe (épidémiologie)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hémorragie (prévention et contrôle)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (sang)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Maladie grave (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (sang)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Produits de dégradation de la fibrine et du fibrinogène (analyse)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Thromboembolisme veineux (complications)</term>
<term>Thromboembolisme veineux (prévention et contrôle)</term>
<term>Thromboembolisme veineux (thérapie)</term>
<term>Thrombose veineuse (complications)</term>
<term>Thrombose veineuse (prévention et contrôle)</term>
<term>Troubles de l'hémostase et de la coagulation (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Fibrin Fibrinogen Degradation Products</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>China</term>
<term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Produits de dégradation de la fibrine et du fibrinogène</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Pulmonary Embolism</term>
<term>Venous Thromboembolism</term>
<term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Blood Coagulation Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Hemorrhage</term>
<term>Pulmonary Embolism</term>
<term>Venous Thromboembolism</term>
<term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Embolie pulmonaire</term>
<term>Hémorragie</term>
<term>Thromboembolisme veineux</term>
<term>Thrombose veineuse</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Embolie pulmonaire</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Thromboembolisme veineux</term>
<term>Thrombose veineuse</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Venous Thromboembolism</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Thromboembolisme veineux</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Troubles de l'hémostase et de la coagulation</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Chine</term>
<term>Europe</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Consensus</term>
<term>Critical Illness</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Registries</term>
<term>Risk Assessment</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Appréciation des risques</term>
<term>Betacoronavirus</term>
<term>Consensus</term>
<term>Enregistrements</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Maladie grave</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32316065</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>120</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Thrombosis and haemostasis</Title>
<ISOAbbreviation>Thromb. Haemost.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.</ArticleTitle>
<Pagination><MedlinePgn>937-948</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1710019</ELocationID>
<Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.</AbstractText>
<CopyrightInformation>Georg Thieme Verlag KG Stuttgart · New York.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhai</LastName>
<ForeName>Zhenguo</ForeName>
<Initials>Z</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName>
<ForeName>Chenghong</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName>
<ForeName>Yaolong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Gerotziafas</LastName>
<ForeName>Grigorios</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Zhang</LastName>
<ForeName>Zhenlu</ForeName>
<Initials>Z</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Wan</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Liu</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Elalamy</LastName>
<ForeName>Ismaïl</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="N"><LastName>Wang</LastName>
<ForeName>Chen</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>Chinese Academy of Engineering emergency research and cultivation project for COVID-19</GrantID>
<Agency>2020-KYGG-01-05</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>National Key Research and Development Program of China</GrantID>
<Agency>2016YFC0905600</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>National Key Research and Development Program of China</GrantID>
<Agency>2016YFC0901104</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>CAMS Innovation Fund for Medical Sciences</GrantID>
<Agency>2018-I2M-1-003</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>National Natural Science Foundation of China</GrantID>
<Agency>81570049</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>National Natural Science Foundation of China</GrantID>
<Agency>81970058</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Thromb Haemost</MedlineTA>
<NlmUniqueID>7608063</NlmUniqueID>
<ISSNLinking>0340-6245</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32316065</ArticleId>
<ArticleId IdType="doi">10.1055/s-0040-1710019</ArticleId>
<ArticleId IdType="pmc">PMC7295267</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Blood Adv. 2018 Nov 27;2(22):3198-3225</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30482763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Jan 27;10(1):e0116835</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25625201</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2010 Nov;8(11):2450-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20738765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32073213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2019 Sep 12;42(9):660-684</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31484242</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Coll Cardiol. 2020 May 12;75(18):2352-2371</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32201335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2013 Feb;39(2):165-228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23361625</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1851-1852</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32172226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2015 Aug 18;19:287</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26283414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacotherapy. 2019 Aug;39(8):837-853</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31233222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2017 Jan 17;166(2):128-132</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27893062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Heart J. 2020 Jan 21;41(4):543-603</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2010 Dec 14;182(18):E839-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20603348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood Adv. 2018 Nov 27;2(22):3360-3392</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30482768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Mar 13;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 7;395(10226):809-815</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32151335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2019 Apr 4;380(14):1305-1315</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30779530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anesth Analg. 2018 Mar;126(3):928-944</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29099429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Kidney J. 2014 Oct;7(5):442-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25878775</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Anaesthesiol. 2018 Feb;35(2):142-146</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29112545</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Intern Med. 2016 Feb;31(2):147-148</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26658933</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thromb Haemost. 2016 Oct 28;116(5):843-851</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27411507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Cardiovasc Drugs. 2020 Jun;20(3):223-228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31721053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32220112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2005 Mar 1;171(5):518-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15591472</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619838052</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30939900</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
<li>Russie</li>
<li>République populaire de Chine</li>
</country>
<region><li>District fédéral central</li>
<li>Hubei</li>
<li>Île-de-France</li>
</region>
<settlement><li>Moscou</li>
<li>Paris</li>
<li>Pékin</li>
<li>Wuhan</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhai, Zhenguo" sort="Zhai, Zhenguo" uniqKey="Zhai Z" first="Zhenguo" last="Zhai">Zhenguo Zhai</name>
</noRegion>
<name sortKey="Chen, Yaolong" sort="Chen, Yaolong" uniqKey="Chen Y" first="Yaolong" last="Chen">Yaolong Chen</name>
<name sortKey="Li, Chenghong" sort="Li, Chenghong" uniqKey="Li C" first="Chenghong" last="Li">Chenghong Li</name>
<name sortKey="Liu, Peng" sort="Liu, Peng" uniqKey="Liu P" first="Peng" last="Liu">Peng Liu</name>
<name sortKey="Wan, Jun" sort="Wan, Jun" uniqKey="Wan J" first="Jun" last="Wan">Jun Wan</name>
<name sortKey="Wan, Jun" sort="Wan, Jun" uniqKey="Wan J" first="Jun" last="Wan">Jun Wan</name>
<name sortKey="Wan, Jun" sort="Wan, Jun" uniqKey="Wan J" first="Jun" last="Wan">Jun Wan</name>
<name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<name sortKey="Wang, Chen" sort="Wang, Chen" uniqKey="Wang C" first="Chen" last="Wang">Chen Wang</name>
<name sortKey="Zhai, Zhenguo" sort="Zhai, Zhenguo" uniqKey="Zhai Z" first="Zhenguo" last="Zhai">Zhenguo Zhai</name>
<name sortKey="Zhai, Zhenguo" sort="Zhai, Zhenguo" uniqKey="Zhai Z" first="Zhenguo" last="Zhai">Zhenguo Zhai</name>
<name sortKey="Zhang, Zhenlu" sort="Zhang, Zhenlu" uniqKey="Zhang Z" first="Zhenlu" last="Zhang">Zhenlu Zhang</name>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Gerotziafas, Grigorios" sort="Gerotziafas, Grigorios" uniqKey="Gerotziafas G" first="Grigorios" last="Gerotziafas">Grigorios Gerotziafas</name>
</region>
<name sortKey="Elalamy, Ismail" sort="Elalamy, Ismail" uniqKey="Elalamy I" first="Ismaïl" last="Elalamy">Ismaïl Elalamy</name>
</country>
<country name="Russie"><region name="District fédéral central"><name sortKey="Elalamy, Ismail" sort="Elalamy, Ismail" uniqKey="Elalamy I" first="Ismaïl" last="Elalamy">Ismaïl Elalamy</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000883 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000883 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32316065
   |texte=   Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32316065" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki